1. Home
  2. SCM vs CTKB Comparison

SCM vs CTKB Comparison

Compare SCM & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stellus Capital Investment Corporation

SCM

Stellus Capital Investment Corporation

HOLD

Current Price

$12.51

Market Cap

397.8M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$5.20

Market Cap

433.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCM
CTKB
Founded
2012
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.8M
433.8M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
SCM
CTKB
Price
$12.51
$5.20
Analyst Decision
Hold
Hold
Analyst Count
1
4
Target Price
$13.00
$5.88
AVG Volume (30 Days)
212.6K
1.9M
Earning Date
11-10-2025
11-05-2025
Dividend Yield
12.80%
N/A
EPS Growth
N/A
N/A
EPS
1.09
N/A
Revenue
$102,538,895.00
$196,828,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.62
P/E Ratio
$11.44
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.19
$2.37
52 Week High
$15.56
$7.30

Technical Indicators

Market Signals
Indicator
SCM
CTKB
Relative Strength Index (RSI) 60.12 53.94
Support Level $11.93 $5.15
Resistance Level $12.28 $5.50
Average True Range (ATR) 0.29 0.43
MACD 0.10 -0.06
Stochastic Oscillator 96.10 33.33

Price Performance

Historical Comparison
SCM
CTKB

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: